Treatment with STS may preserve erectile function by elevating the H2S formation and H2S-generating enzyme expression and enhancing antioxidant capacity via the Nrf2/HO-1 pathway in rats with hyperlipidemia. The gene discussed is HMOX1; the disease is hyperlipidemia.